Monitoring of the pharmacological treatment availability in patients with multiple sclerosis in the Greater Poland population
Introduction There is no clear explanation for the availability of multiple sclerosis (MS) pharmacological treatment for patients in Greater Poland and it can be assumed that the same reason is common in most of the developed countries in the United Europe. As an autoimmune disease MS can overlap wi...
Main Authors: | Przemyslaw Daroszewski, Katarzyna Kaczmarek, Juliusz Huber |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2024-01-01
|
Series: | Rheumatology |
Subjects: | |
Online Access: | https://reu.termedia.pl/Monitoring-of-the-pharmacological-treatment-availability-in-patients-with-multiple,177143,0,2.html |
Similar Items
-
New Strategies for Rehabilitation and Pharmacological Treatment of Fatigue Syndrome in Multiple Sclerosis
by: Ewa Zielińska-Nowak, et al.
Published: (2020-11-01) -
Expert opinion on the pharmacological management of multiple sclerosis in women of childbearing age in Iraq
by: Hayder K. Hassoun, et al.
Published: (2023-02-01) -
Non-pharmacologic Approaches to Dysphagia in Patients with Multiple Sclerosis: A Systematic Review
by: Gülşah Kesik, et al.
Published: (2021-06-01) -
Multiple sclerosis /
by: 546326 Dobson, Ruth, et al.
Published: (2013) -
Multiple sclerosis : recovery of function and neurorehabilitation /
by: Kesselring, Jurg, et al.
Published: (c201)